3 results
To investigate if rhEPO has a positive effect on MRI/MRA parameters compared to infants with stroke without rhEPO collected from historical data.To investigate if rhEPO (3 dosages of 1000IU/kg/day) for perinatal stroke has no negative side-effects…
Primary objectiveTo identify specific genes in the NO pathway that are turned on or off by inactivity. The results will disclose key-genes in the NO pathway relevant for vascular adaptations. Secondary objectiveTo correlate functional vascular…
Primary objective- To evaluate the efficacy of lenalidomide (RevlimidTM) in low/int-1 risk MDS with or without a treatment with Epo (NeoRecormonTM)/G-CSF (NeupogenTM) in terms of hematological improvement (HI) as defined by the modified response…